Our prostate-specific SKP2 humanized mouse model offers a valuable platform for investigating mechanisms of immune evasion and tumor microenvironment reprogramming during prostate carcinogenesis, exploring the combined effects of oncogenes and tumor suppressors, and evaluating potential agents targeting human SKP2 for prostate cancer prevention, interception and therapy. The gene discussed is SKP2; the disease is urogenital neoplasm.